is semaglutide a biologic new study from UC San Diego offers early clinical evidence that semaglutide, a widely used GLP-1 receptor agonist, may slow biological aging. In a randomized, placebo-controlled trial, researchers observed a 9% Oral Semaglutide Administration and Metabolism

Whether you're cutting, training, or just looking to support your daily energy levels, this formula delivers simple, effective support

Alcohol interacts differently with each alternative

Methylcobalamin should not be used in patients with early hereditary optic nerve atrophy (Lebers disease)

It is less about dramatic intervention and more about preventing preventable noise

Notably, our previous research highlighted how individuals with T2D initiate GLP-1 RA treatment at lower A1c and BMI levels in more recent years (Cartwright et al., 2024), reflecting a trend toward broader and more accessible use of these drugs

Escnez et al